CEO at Macromoltek
Monica Berrondo, Ph.D., is an entrepreneur, scientist, and software engineer. Her expertise lies in using computational approaches to complex scientific problems, in particular, using algorithms for drug discovery and protein design. She is the founder and CEO of Macromoltek, a biotech company using innovative methods to improve research outcomes and reducing the cost associated with drug discovery through computational modeling. Dr. Berrondo began working on the drug discovery process in high school, when she used computational modeling to predict biological processes.
She completed her doctoral degree in Chemical Engineering at the Johns Hopkins University, where she received the NIH’s prestigious Ruth L. Kirschstein fellowship to conduct her doctoral research studying the effects of mutations on protein structure and function.
Dr. Berrondo has authored peer-reviewed scientific articles in journals such as Proteins, JMB, and PLoS One. She has led Macromoltek through Phase I and II SBIR grants from the NSF and the prestigious Y Combinator accelerator in Winter 2018. Dr. Berrondo strives to build a better world by bringing together a multi-disciplinary team to work on big problems.